Towards a single-assay approach: a combined dna/rna sequencing panel eliminates diagnostic redundancy and detects clinically-relevant fusions in neuropathology

HIGHLIGHTS

• who: Cheyanne C. Slocum from the (UNIVERSITY) have published the research work: Towards a single-assay approach: a combined DNA/RNA sequencing panel eliminates diagnostic redundancy and detects clinically-relevant fusions in neuropathology, in the Journal: (JOURNAL)
• what: The authors demonstrate that the Oncomine Cancer Gene Mutation Panel v2 assay targeted-next generation sequencing panel for solid tumors is not only superior to IHC in detecting mutation in IDH1/2 and TP53 but can also predict 1p/19q co-deletion with high sensitivity and specificity relative to fluorescence in-situ hybridization by looking at average . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.